Indian regulator okays 3 indigenous monkeypox kits

Tribune News Service

Updated At : 07:18 AM Aug 30, 2024 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, August 29

India today took a significant step in combating monkeypox with apex drug regulator granting manufacturing licenses for real-time diagnosis to three indigenously developed in vitro kits.

RT-PCR kits for Mpox virus have been developed by three Indian firms in collaboration with the ICMR. The World Health Organisation (WHO) has declared Mpox as a public health emergency of international concern.

The Indian firms are Siemens Healthcare, Transasia Diagnostics and JITM C Genes.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles